Reggiani Vilela Goncalves

Dr. Reggiani Vilela Goncalves

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2024 in Antioxidants
Verified
Journal Article
Open access
PDF file
FLFernanda Barbosa Lopes
Fernanda Barbosa Lopes
Mariaurea Matias SarandyMariaurea Matias Sarandy
Mariaurea Matias Sarandy
Romulo Dias NovaesRomulo Dias Novaes
Romulo Dias Novaes
Giuseppe ValacchiGiuseppe Valacchi
Giuseppe Valacchi
Reggiani Vilela GoncalvesReggiani Vilela Goncalves
Reggiani Vilela Goncalves
Significant sums are spent every year to find effective treatments to control inflammation and speed up the repair of damaged skin. This study investigated the main mechanisms involved in the skin wound cure. Consequently, it offered guidance to develop new therapies to control OxInflammation and infection and decrease functional loss and cost issues. This systematic review was conducted using the PRISMA guidelines, with a structured search in the MEDLINE (PubMed), Scopus, and Web of Science databases, analyzing 23 original studies. Bias analysis and study quality were assessed using the SYRCLE tool (Prospero number is CRD262 936). Our results highlight the activation of membrane receptors (IFN-δ, TNF-α, toll-like) in phagocytes, especially macrophages, during early wound healing. The STAT1, IP3, and NF-kβ pathways are positively regulated, while Ca2+ mobilization correlates with ROS production and NLRP3 inflammasome activation. This pathway activation leads to the proteolytic cleavage of caspase-1, releasing IL-1β and IL-18, which are responsible for immune modulation and vasodilation. Mediators such as IL-1, iNOS, TNF-α, and TGF-β are released, influencing pro- and anti-inflammatory cascades, increasing ROS levels, and inducing the oxidation of lipids, proteins, and DNA. During healing, the respiratory burst depletes antioxidant defenses (SOD, CAT, GST), creating a pro-oxidative environment. The IFN-δ pathway, ROS production, and inflammatory markers establish a positive feedback loop, recruiting more polymorphonuclear cells and reinforcing the positive interaction between oxidative stress and inflammation. This process is crucial because, in the immune system, the vicious positive cycle between ROS, the oxidative environment, and, above all, the activation of the NLRP3 inflammasome inappropriately triggers hypoxia, increases ROS levels, activates pro-inflammatory cytokines and inhibits the antioxidant action and resolution of anti-inflammatory cytokines, contributing to the evolution of chronic inflammation and tissue damage.

1 November 2020 in Food Research International
Verified
Journal Article
Closed access
BCBruna Cruz
Bruna Cruz
LCLisiane Lopes da Conceição
Lisiane Lopes da Conceição
TMTiago Antônio de Oliveira Mendes
Tiago Antônio de Oliveira Mendes
CFCélia Lúcia de Luces Fortes Ferreira
Célia Lúcia de Luces Fortes Ferreira
Reggiani Vilela GoncalvesReggiani Vilela Goncalves
Reggiani Vilela Goncalves
MPMaria Do Carmo Gouveia Peluzio
Maria Do Carmo Gouveia Peluzio

1 January 2018 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
ABAnderson Baptista
Anderson Baptista
Reggiani Vilela GoncalvesReggiani Vilela Goncalves
Reggiani Vilela Goncalves
JBJosefina Bressan
Josefina Bressan
MPMaria Do Carmo Gouveia Peluzio
Maria Do Carmo Gouveia Peluzio
The accentuated increase in the use of medicinal plants by the population to treat diseases makes it necessary to carry out pharmacological studies in order to contribute to the scientific knowledge and clarify the mechanisms involved in the main compounds present in these plants. Due to the difficulty of combating antimicrobial‐resistant microorganisms, plants become a low‐cost and effective alternative. The stem, fruit, and leaves of plants are used to measure antioxidant and antimicrobial capacity and to combat the oxidative degradation of free radicals produced in the presence of xenobiotics. A systematic review is a powerful tool that incorporates the variability among the studies, providing an overall estimate of the use of plant extracts as antioxidants and antimicrobial activities. In view of the controversies in the literature regarding the use of compounds from plants or the isolation and purification of the main substances for the prevention of bacterial various therapeutic actions, the aim of this was to present a systematic review on the antimicrobial and antioxidant properties of cashew(Anacardium occidentale), cajui(Anacardium microcarpum), and pequi(Caryocar brasiliense). The following databases were analyzed: PubMed/Medline, Virtual Health Library (LILACS and SciELO), and Science Direct. Out of 425 articles, 33 articles have been used in this study, which were also represented in the Prisma Statement.In vitroantioxidant tests were conducted in 28 studies using different methodologies. Most of the tests involving the studied species demonstrated positive antioxidant potential and antimicrobial properties. The results provide important data and perspectives into the use of natural products that can contribute to the treatment of various diseases.

1 June 2016 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
Romulo Dias NovaesRomulo Dias Novaes
Romulo Dias Novaes
MSMarcus Vinicius Pessoa Sartini
Marcus Vinicius Pessoa Sartini
JRJoão Paulo Ferreira Rodrigues
João Paulo Ferreira Rodrigues
Reggiani Vilela GoncalvesReggiani Vilela Goncalves
Reggiani Vilela Goncalves
ESEliziária Cardoso Santos
Eliziária Cardoso Santos
ICIvo Santana Caldas
Ivo Santana Caldas
Although curcumin can increase the effectiveness of drugs against malaria, combination therapies using this molecule have never been investigated in Chagas disease (ChD). Thus, we evaluated the efficacy of curcumin as a complementary strategy to benznidazole (Bz)-based chemotherapy in mice acutely infected with Trypanosoma cruzi. Eighty-four 12-week-old Swiss mice were equally randomized into seven groups: uninfected (NI); T. cruzi-infected and non-treated (INF), infected and treated with 100 mg/kg Bz (B100), 50 mg/kg Bz (B50), 100 mg/kg curcumin (C100); 100 mg/kg Bz + 100 mg/kg curcumin (B100+C100); 50 mg/kg Bz + 100 mg/kg curcumin (B50+C100). After microscopic identification of blood trypomastigotes (4 days after inoculation), both drugs were administered by gavage once a day for 20 days. Curcumin showed limited antiparasitic, anti-inflammatory and antioxidant effects when administered alone. When curcumin and Bz were combined, there was a drastic reduction in parasitemia, parasite load, mortality, anti-T. cruzi IgG reactivity, circulating levels of cytokines (IFN-γ, IL-4 and MIP1-α), myocardial inflammation, morphological and oxidative cardiac injury; these results exceeded the isolated effects of Bz. The combination of Bz and curcumin was also effective at mitigating liver toxicity triggered by Bz, increasing the parasitological cure rate and preventing infection recrudescence in non-cured animals, even when the animals were treated with 50% of the recommended therapeutic dose of Bz. By limiting the toxic effects of Bz and enhancing its antiparasitic efficiency, the combination of this drug with curcumin may be a relevant therapeutic strategy that is possibly better tolerated in ChD treatment compared with Bz-based monotherapy.

10 October 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LALuciana Schulthais Altoé
Luciana Schulthais Altoé
RARaul Santos Alves
Raul Santos Alves
MSMariáurea Matias Sarandy
Mariáurea Matias Sarandy
MMMônica Morais-Santos
Mônica Morais-Santos
Romulo Dias NovaesRomulo Dias Novaes
Romulo Dias Novaes
Reggiani Vilela GoncalvesReggiani Vilela Goncalves
Reggiani Vilela Goncalves
The presence of infections is one of the main factors that leads to delays in healing or non-closure of cutaneous wounds. Although the goal of antibiotic use is to treat or prevent infection, there is currently no agreement on the effectiveness of these products. The aim of this study was to evaluate the efficacy of antibiotic use during the healing process of skin wounds in animal models not intentionally infected, as well as to analyze the advances and limitations of the studies carried out in this field. This systematic review was performed according to the PRISMA guidelines, using a structured search on the MedLine (PubMed) and Scopus platforms to retrieve studies published until August 29, 2018, 13:35p.m. The studies included were limited to those that used excision or incision wound models and that were not intentionally infected. The data for the animal models, antibiotic used, and the main results of the studies were extracted, and compared where possible. Bias analysis and methodological quality assessments were examined through the SYRCLE’s Risk of Bias tool. Twenty-seven studies were selected. Overall, the effects of the antibiotic on the wound decreased inflammatory cell infiltration and promoted an increased number of fibroblasts, extracellular matrix constituents, re-epithelialization and tissue strength. A great deal of important information about the methodology was not presented, such as: the statistical analysis used, the animal model (sex and age), antibiotic dosage, blinding and randomization of the animals chosen. Based on the results found, we believe that antibiotic therapy can be considered a viable alternative for the treatment of cutaneous wounds. However, current evidence obtained from the methodological quality analysis points towards a high risk of bias. This is due to the incomplete characterization of the experimental design and treatment protocol, which compromises the reproducibility of the studies.

10 July 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
PMPatricia da Silva Mattosinhos
Patricia da Silva Mattosinhos
MSMariáurea Matias Sarandy
Mariáurea Matias Sarandy
Romulo Dias NovaesRomulo Dias Novaes
Romulo Dias Novaes
Debora EspositoDebora Esposito
Debora Esposito
Reggiani Vilela GoncalvesReggiani Vilela Goncalves
Reggiani Vilela Goncalves
The Brassicaceae family constitutes some of the most well-studied natural products in the world, due to their anti-inflammatory, anti-oxidative, and pro-regenerative properties as well as their ubiquitous distribution across the world. To evaluate the potential efficacy of the Brassicaceae family in the treatment of inflammatory skin disorders and wounds, based on preclinical evidence from in vivo and in vitro studies. This systematic review was performed according to the PRISMA guidelines, using a structured search on the PubMed-Medline, Scopus, and Web of Science platforms. The studies included were those that used murine models and in vitro studies to investigate the effect of Brassicaceae on skin disorders. Bias analysis and methodological quality assessments were examined through SYRCLE’s RoB tool. Brassicaceae have shown positive impacts on inflammatory regulation of the skin, accelerating the wound healing process, and inhibiting the development of edema. The studies showed that the Brassicaceae family has antioxidant activity and effects on the modulation of cyclooxygenase 2 and the nuclear factor kappa β (NFκβ) pathway. The secondary metabolites present in Brassicas are polyphenols (68.75%; n = 11), terpenes/carotenoids (31.25%; n = 5), and glycosylates (25%; n = 4), which are responsible for their anti-inflammatory, healing, and antioxidant effects. In addition, the current evidence is reliable because the bias analysis showed a low risk of bias. Our review indicates that compounds derived from Brassicaceae present exceptional potential to treat inflammatory skin diseases and accelerate cutaneous wound healing. We hope that our critical analysis can help to expedite clinical research and to reduce methodological bias, thereby improving the quality of evidence in future research. The registration number on the Prospero platform is CRD42021262953.